Capital Change Notice - Issue of Performance Share Rights

Capital Change Notice



9 September 2026
Issue of Performance Share Rights
This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Performance Share Rights to
acquire ordinary shares in the Company (‘PSRs’) issued under the Fisher & Paykel Healthcare 2025
Performance Share Rights Plan (‘PSR Plan’) and the Fisher & Paykel Healthcare 2025 Performance Share
Rights Plan – North America (‘North America Plan’).

Section 1: Issuer information
Name of issuer Fisher & Paykel Healthcare
Corporation Limited
NZX ticker code FPH
Class of financial product Unlisted PSRs issued under the
PSR Plan and the North America
Plan.
ISIN (If unknown, check on NZX website) NZFAPE0001S2
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 223,505
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security No amount is payable for the grant
of PSRs. One PSR gives the
participant the potential to
exercise that PSR for one ordinary
share at no cost.
Nature of the payment (for example, cash or other consideration) Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of Financial
Products of the Class, excluding any Treasury Stock, in existence)
1

223,505 PSRs represent
approximately 0.0380% of the
ordinary shares on issue.
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion price and
Conversion date and the ranking of the Financial Product in relation
to other Classes of Financial Product) or the Option (for example,
the exercise price and exercise date)
Not applicable
Reason for issue/acquisition/redemption and specific authority for
issue/acquisition/redemption/ (the reason for change must be
identified here)
Issue of PSRs under the PSR
Plan and the North America Plan
to incentivise selected employees
to grow the Company and to
attract, motivate and retain key
employees.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury Stock)
and the total number of Financial Products of the Class held as
Treasury Stock after the issue/acquisition/redemption.
Total number of PSRs on issue as
at the date of this notice after the
issue disclosed in this notice:
1,087,097
In the case of an acquisition of shares, whether those shares are to
be held as treasury stock
Not applicable

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Specific authority for the issue, acquisition, or redemption, including
a reference to the rule pursuant to which the issue, acquisition, or
redemption is made
Directors’ resolution dated 25
August 2026.
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The PSRs will be issued on the
terms of the PSR Plan and the
North America Plan, as approved
by the Board.
Date of issue/acquisition/redemption
2
8 September 2026
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Raelene Leonard
Contact person for this announcement Raelene Leonard
Contact phone number +64 9 610 4803
Contact email address Raelene.Leonard@fphcare.co.nz
Date of release through MAP

9 September 2026







2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were
made (for example, 1 January 2019 to 31 January 2019).